Latest 8-K filings

Hyperfine, Inc. announced preliminary unaudited third-quarter 2026 revenue of approximately $6.0 million, a 53% sequential increase, alongside a reduced net cash burn.

ConnectOne Bancorp, Inc. announced its plan to release third quarter 2026 financial results on October 22, 2026, followed by a management-hosted conference call.

Virginia National Bankshares Corporation has authorized a new share repurchase program allowing for the buyback of up to $18.7 million of its common stock over the next year.

AngioDynamics announced its fiscal first quarter 2027 financial results, showcasing 6.9% total net sales growth driven by a 13.2% increase in the Med Tech segment, alongside the appointment of a new CEO.

AngioDynamics announced the appointment of Eric Honroth as its new President and CEO, effective November 2, 2026, succeeding James C. Clemmer who will transition to a consulting role.

Crescent Energy Company announced a definitive agreement to acquire significant Eagle Ford assets from Devon Energy for approximately $4.2 billion, bolstering its position in the basin.

Shoulder Innovations announces the limited user release of its next-generation glenoid implant, InSet Go, following a successful first surgical case.

Editas Medicine has received approval to initiate its Phase 1/2 Strive clinical trial for EDIT-401 in Australia and New Zealand, targeting hyperlipidemia.

TETRA Technologies, Inc. has entered into a First Amendment to its Term Loan Credit Agreement, reducing interest rates, extending the maturity date, and modifying amortization schedules.

Vontier Corporation announces the resignation of Executive Vice President, Chief Transformation and Operations Officer, Kathryn Rowen, effective October 16, 2026.

Tilray Brands announced record first-quarter fiscal 2027 revenue of $257.1 million, up 23% year-over-year, with gross margin expanding to 30%.

Henry Schein announces a planned CFO transition, with Emmanuel Caprais succeeding Ronald N. South, who will move to a Senior Advisor role.

Venture Global Calcasieu Pass, LLC has been informed by the ICC International Court of Arbitration that a partial final award was issued against it in an arbitration with Galp Trading S.A. concerning LNG sales.

Atrium Therapeutics announced a $50 million private placement financing, selling shares and pre-funded warrants to accredited investors to fund its RNA therapeutics development.

Helen of Troy reported a 2.1% increase in net sales for Q2 FY27, alongside significant improvements in profitability and an updated, more optimistic fiscal year outlook.

Nova Minerals Corp has successfully delivered key equipment for its antimony processing plant and is poised to commence construction, marking a significant step towards a domestic U.S. antimony supply chain.

Frequency Electronics, Inc. reported on its Annual Meeting of Stockholders held on October 7, 2026, where directors were elected, Grant Thornton LLP was ratified as auditor, and executive compensation was approved on an advisory basis.

Perspective Therapeutics announced its investigational drug PSV359 has received FDA Fast Track Designation for treating specific solitary fibrous tumors, potentially accelerating its development and review.

Drilling Tools International Corp. announced a definitive agreement to acquire Saltire Energy Limited and Foxley Energy Limited for approximately $80 million in cash and 17.4 million shares of DTI common stock.

Haemonetics Corporation provides an update on its supply agreement with CSL Plasma, indicating CSL expects to complete device and disposable rollout by end of 2027.

New Era Energy & Digital, Inc. has entered into a Letter of Credit Reimbursement Agreement for $116 million to support its subsidiary's power purchase agreement, alongside a strategic shift to direct leasing for its data center project.

Prudential Financial, Inc. disclosed findings from an investigation into misconduct by sales employees of its Japanese subsidiaries and outlined extensive remediation plans.

The Brink's Company announced that the UK's Competition and Markets Authority has accepted in principle a proposed remedy for the acquisition of NCR Atleos, keeping the deal on track for an early 2027 close.

Valion Bio, Inc. has entered into a letter agreement with 3i, LP to issue 50 shares of Series B Preferred Stock and accompanying warrants for $50,000, furthering its financing efforts.

Eva Live Inc. has entered into a securities purchase agreement with Dune Equity Holdings LLC for a secured promissory note of up to $1,875,000, with an original issue discount and conversion rights.

Distribution Solutions Group, Inc. announced the pricing of an $800 million senior notes offering, increasing the initial amount, to fund a previously announced merger and repay debt.

Texas Ventures Acquisition III Corp has issued a $250,000 convertible unsecured promissory note to its sponsor, Yorkville Acquisition Sponsor II, LLC, to bolster working capital.

CTT Pharmaceutical Holdings, Inc. announced the resignation of its independent registered public accounting firm, Holt & Patterson, LLC, citing the firm's decision to no longer handle SEC reporting companies.

Scienture Holdings, Inc. has announced a 1-for-25 reverse stock split, effective October 5, 2026, to regain compliance with Nasdaq's minimum bid price requirement.

Stewards, Inc. has filed an amendment to its previous 8-K, updating pro forma financial information for its Envy Pompano Beach acquisition, primarily reclassifying escrowed shares as a liability.